Find Research Outputs

Search results

• 2011

  A genome-wide association study identifies potential susceptibility Loci for hepatotoxicity due to various drugs

  Urban, T., Shen, Y., Chalasani, N. P., Fontana, R. J., Rochon, J., Stolz, A., Serrano, J. A., Aithal, G. P., Daly, A., Dillon, J. F., Floraros, A., Molokhia, M., Lucena, M. I., Goldstein, D. B. & Watkins, P. B., May 2011, In: Gastroenterology. 140, 5 Suppl. 1, p. S886-S886 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota

  Steed, H., Macfarlane, G. T., Blackett, K. L., Macfarlane, S., Miller, M. H., Bahrami, B. & Dillon, J. F., Dec 2011, In: FEMS Immunology and Medical Microbiology. 63, 3, p. 346-354 9 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)

• Barrett's esophagus: proton pump inhibitors and chemoprevention I

  Triadafilopoulos, G., Taddei, A., Bechi, P., Freschi, G., Ringressi, M. N., Degli'Innocenti, D. R., Castiglione, F., Masini, E., Majewski, M., Wallner, G., Sarosiek, J., Dillon, J. F., Mccallum, R. C., Dvorak, K., Goldman, A., Woodland, P., Sifrim, D., Richter, J. E., Vieth, M., Neumann, H. & 4 others, Langner, C., Ishimura, N., Amano, Y. & Felix, V. N., Sep 2011, In: Annals of the New York Academy of Sciences. 1232, 1, p. 93-113 21 p.

  Research output: Contribution to journal › Article › peer-review

  • Chemoprevention
  • Barrett Esophagus
  • Proton Pump Inhibitors
  • Normalization
  • Therapy
  2 Citations (Scopus)

• Does geographic access to primary healthcare influence the detection of hepatitis C?

  Astell-Burt, T., Flowerdew, R., Boyle, P. J. & Dillon, J. F., 2011, In: Social Science and Medicine. 72, 9, p. 1472-1481 10 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)

• Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care

  Innes, H. A., Hutchinson, S. J., Allen, S. H., Bhattacharyya, D., Bramley, P., Delahooke, T. E. S., Dillon, J. F., Forrest, E., Fraser, A., Gillespie, R., Goldberg, D. J., Kennedy, N., McDonald, S., McLeod, A., Mills, P. R., Morris, J. & Hayes, P., Nov 2011, In: Hepatology. 54, 5, p. 1547-1558

  Research output: Contribution to journal › Article › peer-review
  55 Citations (Scopus)

• Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006

  McDonald, S. A., Hutchinson, S. J., Bird, S. M., Mills, P. R., Hayes, P., Dillon, J. F. & Goldberg, D. J., 2011, In: Epidemiology and Infection. 139, 3, p. 344-353 10 p.

  Research output: Contribution to journal › Article › peer-review
  14 Citations (Scopus)

• Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection

  McDonald, S. A., Hutchinson, S. J., Bird, S. M., Robertson, C., Mills, P. R., Dillon, J. F. & Goldberg, D. J., Jan 2011, In: International Journal of Drug Policy. 22, 1, p. 63-69 7 p.

  Research output: Contribution to journal › Article › peer-review
  5 Citations (Scopus)

• Is it worth testing unstable drug users for Hepatitis C?

  Stephens, B. P., Tait, J. & Dillon, J. F., Oct 2011, In: Hepatology. 54, S1, p. 844A-844A 1 p.

  Research output: Contribution to journal › Special issue › peer-review
  1 Citation (Scopus)

• Novel non-invasive scoring system for the detection of NASH from a NAFLD population

  Miller, M., Jafferbhoy, H., Crowther, D., Walsh, S., Ferguson, M. A. & Dillon, J. F., Oct 2011, In: Hepatology. 54, p. 1113A-1113A 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review
  1 Citation (Scopus)

• Predictors of neoplasia in patients presenting with obstructive jaundice

  Smith, A., Miller, M., Groome, M. & Dillon, J. F., Oct 2011, In: Hepatology. 54, S1, p. 1423A-1424A 2 p.

  Research output: Contribution to journal › Special issue › peer-review
  1 Citation (Scopus)

• Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR

  Jafferbhoy, H., Miller, M. H., El Wahed, Z. & Dillon, J. F., 2011, In: Journal of Hepatology. 55, 5, p. 1162-1164 3 p.

  Research output: Contribution to journal › Letter › peer-review
  5 Citations (Scopus)

• Response and predictors of response, to pegylated interferon and ribavirin for chronic hepatitis C patients in Scotland: alanine aminotransferase (ALT) and gamma glutamyl transferase (GGT) are valuable pre-treatment markers of an SVR in routine clinical practice

  Innes, H., Hutchinson, S., Allen, S., Bhattacharyya, D., Bramley, P., Carman, B., Delahooke, T., Dillon, J., Goldberg, D., Kennedy, N., Mills, P., Morris, J., Stanley, A. & Hayes, P., 2011, In: Journal of Epidemiology and Community Health. 65, Supplement 1, p. A254 1 p., P2-122.

  Research output: Contribution to journal › Meeting abstract › peer-review
  20 Citations (Scopus)

• Spontaneous bacterial peritonitis prophylaxis: reducing the incidence of hospital acquired infection

  Jafferbhoy, H., Miller, M., Shekar, C. C., Lockhart, M. & Dillon, J. F., Oct 2011, In: Hepatology. 54, S1, p. 1239A-1240A 2 p.

  Research output: Contribution to journal › Special issue › peer-review
  1 Citation (Scopus)

• Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles

  Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz-Cabello, F., Donaldson, P. T., Stephens, C., Pirmohamed, M., Romero-Gomez, M., Navarro, J. M., Fontana, R. J., Miller, M., Groome, M., Bondon-Guitton, E., Conforti, A., Stricker, B. H. C., Carvajal, A. & 12 others, Ibanez, L., Yue, Q-Y., Eichelbaum, M., Floratos, A., Pe'er, I., Daly, M. J., Goldstein, D. B., Dillon, J. F., Nelson, M. R., Watkins, P. B., Daly, A. K. & Int SAEC, EUDRAGENE, Spanish DILI Registry, DILIGEN, DILIN, 2011, In: Gastroenterology. 141, 1, p. 338-347 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  309 Citations (Scopus)

• Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease

  Miller, M. H., Ferguson, M. A. J. & Dillon, J. F., Apr 2011, In: Liver International. 31, 4, p. 461-473 13 p.

  Research output: Contribution to journal › Review article › peer-review
  37 Citations (Scopus)

• The development and external validation of a model to predict one year all-cause mortality following liver function tests in primary care patients

  McLernon, D. J., Dillon, J. F. & Donnan, P. T., 2011, In: Value in Health. 14, 7, p. A392 1 p.

  Research output: Contribution to journal › Article › peer-review

• The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow

  McDonald, S., Hutchinson, S., Mills, P., Bird, S., Cameron, S., Dillon, J. & Goldberg, D., 2011, In: Journal of Epidemiology and Community Health. 65, p. A271 1 p.

  Research output: Contribution to journal › Book/Film/Article review › peer-review

• The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population

  McDonald, S. A., Hutchinson, S. J., Mills, P. R., Bird, S. M., Cameron, S., Dillon, J. F. & Goldberg, D. J., 2011, In: Journal of Viral Hepatitis. 18, 4, p. e126-e133 8 p.

  Research output: Contribution to journal › Article › peer-review
  13 Citations (Scopus)
• 2012

  HCV research UK: a UK national resource to support research into HCV infection

  Irving, W., McLauchlan, J., Foster, G., Dillon, J., Hutchinson, S. & Wilkes, B., Jul 2012, In: Gut. 61, Suppl. 2, p. A147-A148 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection

  Jafferbhoy, H., Miller, M. H., Dunbar, J. K., Tait, J., Mcleod, S. & Dillon, J. F., Feb 2012, In: Journal of Viral Hepatitis. 19, 2, p. 112-119 8 p.

  Research output: Contribution to journal › Article › peer-review
  12 Citations (Scopus)

• Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?

  Astell-Burt, T., Flowerdew, R., Boyle, P. & Dillon, J., 1 Jan 2012, In: Social Science and Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Time Travel
  • Virus
  • Hepatitis C
  • contagious disease
  • Hepacivirus
  14 Citations (Scopus)

• Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant

  Palmer, C. N. A., Maglio, C., Pirazzi, C., Burza, M. A., Adiels, M., Burch, L., Donnelly, L. A., Colhoun, H., Doney, A. S., Dillon, J. F., Pearson, E. R., McCarthy, M., Hattersley, A. T., Frayling, T., Morris, A. D., Peltonen, M., Svensson, P-A., Jacobson, P., Borén, J., Sjöström, L. & 2 others, Carlsson, L. M. S. & Romeo, S., 2012, In: PLoS ONE. 7, 6, e39362.

  Research output: Contribution to journal › Article › peer-review

  • patatin
  • noninsulin-dependent diabetes mellitus
  • Phospholipases
  • Medical problems
  • phospholipases
  61 Citations (Scopus)

• Quantifying the extent of cirrhosis attributable to alcohol among patients chronically infected with hepatitis c: implications for treatment cost-effectiveness studies

  Innes, H. A., Hutchinson, S. J., Amanda, W., Dillon, J. F., Goldberg, D. J., Mills, P. R., Morris, J., Stanley, A., Hayes, P. & Hepatitis C Clinical Database Moni, Apr 2012, In: Journal of Hepatology. 56, p. S441-S441 1 p.

  Research output: Contribution to journal › Special issue › peer-review
  63 Citations (Scopus)

• Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland

  Innes, H. A., Hutchinson, S. J., Allen, S., Bhattacharyya, D., Bramley, P., Carman, B., Delahooke, T. E. S., Dillon, J. F., Goldberg, D. J., Kennedy, N., Mills, P. R., Morris, J., Morris, J., Robertson, C., Stanley, A. J., Hayes, P. & Hepatitis C Clinical Database, 2012, In: European Journal of Gastroenterology & Hepatology. 24, 6, p. 646-655 10 p.

  Research output: Contribution to journal › Article › peer-review
  27 Citations (Scopus)

• Spontaneous bacterial peritonitis prophylaxis in the era of healthcare associated infection

  Jafferbhoy, H. M., Miller, M. H., Gashau, W., ChandraShekar, C., Henry, E. B., Lockhart, M. & Dillon, J. F., 2012, In: Gut. 61, 11, p. 1644-1645 2 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Citations (Scopus)

• The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population

  Jafferbhoy, H., Miller, M. H., McIntyre, P. & Dillon, J. F., 2012, In: Epidemiology and Infection. 140, 6, p. 1048-1053 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepatitis C
  • Hepacivirus
  • Population
  • Scotland
  • Chronic Hepatitis B
  14 Citations (Scopus)

• The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)

  McLernon, D. J., Dillon, J. F., Sullivan, F. M., Donnan, P. T., Roderick, P., Rosenberg, W. M. & Ryder, S. D., 14 Dec 2012, In: PLoS ONE. 7, 12, e50965.

  Research output: Contribution to journal › Article › peer-review

  • liver function tests
  • liver function
  • Liver
  • Liver Function Tests
  • Primary Health Care
  10 Citations (Scopus)

• UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

  Ramachandran, P., Fraser, A., Agarwal, K., Austin, A., Brown, A., Foster, G. R., Fox, R., Hayes, P. C., Leen, C., Mills, P. R., Mutimer, D. J., Ryder, S. D. & Dillon, J. F., 2012, In: Alimentary Pharmacology & Therapeutics. 35, 6, p. 647-662 16 p.

  Research output: Contribution to journal › Article › peer-review

  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • telaprevir
  • Chronic Hepatitis C
  • Protease Inhibitors
  • Consensus
  87 Citations (Scopus)
• 2013

  Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

  Miller, M. H. & Dillon, J. F., 1 Jan 2013, In: Alimentary Pharmacology & Therapeutics. 37, 2, p. 275 1 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?

  Paterson, J. C. M. & Dillon, J. F., May 2013, In: Alimentary Pharmacology & Therapeutics. 37, 9, p. 915 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Citation (Scopus)

• Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals

  Martin, N. K., Vickerman, P., Grebely, J., Hellard, M., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J. & Hickman, M., Nov 2013, In: Hepatology. 58, 5, p. 1598-1609 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Drug Design
  • Hepacivirus
  • Antiviral Agents
  • Pharmaceutical Preparations
  • Opiate Alkaloids
  341 Citations (Scopus)

• Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data

  Dunbar, J. K., Dillon, J., Garden, J. & Brewster, D. H., 1 Apr 2013, In: HPB. 15, 4, p. 279-285 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Scotland
  • Hepatocellular Carcinoma
  • Registries
  • Survival
  • Neoplasms
  7 Citations (Scopus)

• Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

  Blackett, K. L., Siddhi, S. S., Cleary, S., Steed, H., Miller, M. H., Macfarlane, S., Macfarlane, G. T. & Dillon, J. F., Jun 2013, In: Alimentary Pharmacology & Therapeutics. 37, 11, p. 1084-1092 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophageal Diseases
  • Barrett Esophagus
  • Gastroesophageal Reflux
  • Biofilms
  • Causality
  86 Citations (Scopus)

• Prevalence estimates of diagnosed viral hepatitis B, liver condition outcomes and hospitalization costs: a population record-linkage study in Tayside, Scotland

  McLernon, D. J., Donnan, P. T. & Dillon, J. F., 2013, In: Epidemiology and Infection. 141, 10, p. 2122-2130 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Scotland
  • Hepatitis B
  • Hepatitis B virus
  • Hepatitis B Surface Antigens
  • Hospitalization
  2 Citations (Scopus)

• Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness

  Innes, H. A., Hutchinson, S. J., Barclay, S., Cadzow, E., Dillon, J. F., Fraser, A., Goldberg, D. J., Mills, P. R., McDonald, S. A., Morris, J., Stanley, A., Hayes, P. & Hepatitis C Clinical Database Monitoring Committee, Feb 2013, In: Hepatology. 57, 2, p. 451-460 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Hepatitis C
  • Hepacivirus
  • Health Care Costs
  • Cost-Benefit Analysis
  • Alcohols
  33 Citations (Scopus)

• The diversity and management of chronic Hepatitis B virus infections in the United Kingdom: a wake-up call

  Tedder, R. S., Rodger, A. J., Fries, L., Ijaz, S., Thursz, M., Rosenberg, W., Naoumov, N., Banatvala, J., Williams, R., Dusheiko, G., Chokshi, S., Wong, T., Rosenberg, G., Moreea, S., Bassendine, M., Jacobs, M., Mills, P. R., Mutimer, D., Ryder, S. D., Bathgate, A. & 8 others, Hussaini, H., Dillon, J. F., Wright, M., Bird, G., Collier, J., Anderson, M., Johnson, A. M. & for the Collaborative UK Study of Chronic Hepatitis B Infection (CUSHI-B) Study Group, 10 Jan 2013, In: Clinical Infectious Diseases. 56, 7, p. 951-960 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Hepatitis B
  • Hepatitis B e Antigens
  • Coinfection
  • Hepatitis B virus
  • Viral Drug Resistance
  25 Citations (Scopus)
• 2018

  Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

  Cunningham, E. B., Amin, J., Feld, J. J., Bruneau, J., Dalgard, O., Powis, J., Hellard, M., Cooper, C., Read, P., Conway, B., Dunlop, A. J., Norton, B., Litwin, A. H., Hajarizadeh, B., Thurnheer, M. C., Dillon, J. F., Weltman, M., Shaw, D., Bruggmann, P., Gane, E. & 8 others, Fraser, C., Marks, P., Applegate, T. L., Quiene, S., Siriragavan, S., Matthews, G. V., Dore, G. J. & Grebely, J., Dec 2018, In: International Journal of Drug Policy. 62, p. 14-23 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • velpatasvir
  • Sofosbuvir
  • Injections
  • Infection
  • Pharmaceutical Preparations
  21 Citations (Scopus)

  66 Downloads (Pure)

• Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial

  Radley, A., de Bruin, M., Inglis, S. K., Donnan, P. T. & Dillon, J. F., 14 Dec 2018, In: BMJ Open. 8, 12, p. 1-8 8 p., e021443.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Pharmacy
  • Pharmacists
  • Hepacivirus
  7 Citations (Scopus)

  156 Downloads (Pure)

• Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease

  Spanos, C., Maldonado, E. M., Fisher, C. P., Leenutaphong, P., Oviedo-Orta, E., Windridge, D., Salguero, F. J., Bermúdez-Fajardo, A., Weeks, M. E., Evans, C., Corfe, B. M., Rabbani, N., Thornalley, P. J., Miller, M. H., Wang, H., Dillon, J. F., Quaglia, A., Dhawan, A., Fitzpatrick, E. & Moore, J. B., 25 Jun 2018, In: Proteome Science. 16, 13, p. 13 1 p., 13.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  File

  • Proteomics
  • Liver
  • Non-alcoholic Fatty Liver Disease
  123 Downloads (Pure)

• Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes

  Miller, M. H., Fraser, A., Leggett, G., MacGilchrist, A., Gibson, G., Orr, J., Forrest, E. H., Dow, E., Bartlett, W., Weatherburn, C., Laurell, A., Grant, K., Scott, K., Neville, R. & Dillon, J. F., Jul 2018, In: Frontline Gastroenterology. 9, 3, p. 175-182 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Function Tests
  • Triage
  • Liver Diseases
  • Datasets
  • Primary Health Care
  3 Citations (Scopus)

  257 Downloads (Pure)

• Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Armstrong, I., Baker, A., Bhala, N., Camps-Walsh, G., Cramp, M. E., de Lusignan, S., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G., Gilmore, I., Hudson, M., Kelly, D., Langford, A., McDougall, N., Meier, P. & 14 others, Moriarty, K., Newsome, P., O'Grady, J., Pryke, R., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Taylor, A., Thompson, J., Thorburn, D., Verne, J., Wass, J. & Yeoman, A., 17 Mar 2018, In: Lancet. 391, 10125, p. 1097-1107 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Cost of Illness
  • Hepatitis
  • Industry
  • Alcohol Drinking
  • Liver Diseases
  62 Citations (Scopus)

  545 Downloads (Pure)

• Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD

  Brennan, P. N. & Dillon, J. F., Jan 2018, In: Alimentary Pharmacology & Therapeutics. 47, 2, p. 299-300 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2)

  Sharma, R. S., Harrison, D. J., Kisielewski, D., Cassidy, D. M., McNeilly, A. D., Gallagher, J. R., Walsh, S. V., Honda, T., McCrimmon, R. J., Dinkova-Kostova, A. T., Ashford, M. L. J., Dillon, J. F. & Hayes, J. D., 1 Mar 2018, In: CMGH: Cellular and Molecular Gastroenterology and Hepatology. 5, 3, p. 367-398 32 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • TBE 31
  • NF-E2-Related Factor 2
  • Fructose
  • Non-alcoholic Fatty Liver Disease
  • Liver Cirrhosis
  62 Citations (Scopus)

  168 Downloads (Pure)

• Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Aspinall, R., Batterham, R., Bhala, N., Bosanquet, N., Severi, K., Burton, A., Burton, R., Cramp, M. E., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G. R., Gilmore, I., Greenberg, J., Henn, C., Hudson, M. & 18 others, Jarvis, H., Kelly, D., Mann, J., McDougall, N., McKee, M., Moriarty, K., Morling, J., Newsome, P., O'Grady, J., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Thorburn, D., Verne, J., Vohra, J., Wass, J. & Yeoman, A., 1 Dec 2018, In: Lancet. 392, 10162, p. 2398-2412 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Diseases
  • Alcohols
  • National Health Programs
  • Obesity
  • England
  28 Citations (Scopus)

  444 Downloads (Pure)

• Guidelines on the management of abnormal liver blood tests

  Newsome, P. N. G., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., Mackie, A., Mitchell-Thain, R., Sennett, K., Sheron, N. C., Verne, J., Walmsley, M. & Yeoman, A., Jan 2018, In: Gut. 67, 1, p. 6-19 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hematologic Tests
  • Guidelines
  • Gastroenterology
  • Liver
  • Biochemistry
  82 Citations (Scopus)

  207 Downloads (Pure)

• Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings: what is required to achieve the WHO's HCV elimination targets?

  Ward, Z., Platt, L., Sweeney, S., Hope, V. D., Maher, L., Hutchinson, S., Palmateer, N., Smith, J., Craine, N., Taylor, A., Martin, N., Ayres, R., Dillon, J., Hickman, M. & Vickerman, P., Sep 2018, In: Addiction. 113, 9, p. 1727-1738 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Hepacivirus
  • Pharmaceutical Preparations
  • Syringes
  16 Citations (Scopus)

  136 Downloads (Pure)

• Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis

  Wang, H., Swann, R., Thomas, E., Innes, H. A., Valerio, H., Hayes, P. C., Allen, S., Barclay, S. T., Wilks, D., Fox, R., Bhattacharyya, D., Kennedy, N., Morris, J., Fraser, A., Stanley, A. J., Gunson, R., Mclntyre, P. G., Hunt, A., Hutchinson, S. J., Mills, P. R. & 1 others, Dillon, J. F., 1 Aug 2018, In: Journal of Viral Hepatitis. 25, 8, p. 930-938 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Chronic Hepatitis C
  • Hepatitis B
  • Hepacivirus
  • Hepatitis B virus
  • Liver
  5 Citations (Scopus)

  146 Downloads (Pure)

• Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe"

  Fraser, H., Martin, N. K., Brummer-Korvenkontio, H., Carrieri, P., Dalgard, O., Dillon, J., Goldberg, D., Hutchinson, S., Jauffret-Roustide, M., Kåberg, M., Matser, A. A., Matičič, M., Midgard, H., Mravcik, V., Øvrehus, A., Prins, M., Reimer, J., Robaeys, G., Schulte, B., van Santen, D. K. & 3 others, Zimmermann, R., Vickerman, P. & Hickman, M., 1 Mar 2018, In: Journal of Hepatology. 68, 3, p. 402-411 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepacivirus
  • Opiate Substitution Treatment
  • Pharmaceutical Preparations
  • Syringes
  • Slovenia
  53 Citations (Scopus)

  145 Downloads (Pure)

• Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease

  Spanos, C., Maldonado, E. M., Fisher, C. P., Leenutaphong, P., Oviedo-Orta, E., Windridge, D., Salguero, F. J., Bermúdez-Fajardo, A., Weeks, M. E., Evans, C., Corfe, B. M., Rabbani, N., Thornalley, P. J., Miller, M. H., Wang, H., Dillon, J. F., Quaglia, A., Dhawan, A., Fitzpatrick, E. & Bernadette Moore, J., 14 Feb 2018, In: Proteome Science. 16, p. 1-16 16 p., 4.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Proteomics
  • Liver
  • Non-alcoholic Fatty Liver Disease
  • Pyruvaldehyde
  • Biopsy
  11 Citations (Scopus)

  215 Downloads (Pure)

• Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

  Grebely, J., Dalgard, O., Conway, B., Cunningham, E. B., Bruggmann, P., Hajarizadeh, B., Amin, J., Bruneau, J., Hellard, M., Litwin, A. H., Marks, P., Quiene, S., Siriragavan, S., Applegate, T. L., Swan, T., Byrne, J., Lacalamita, M., Dunlop, A., Matthews, G. V., Powis, J. & 12 others, Shaw, D., Thurnheer, M. C., Weltman, M., Kronborg, I., Cooper, C., Feld, J. J., Fraser, C., Dillon, J. F., Read, P., Gane, E., Dore, G. J. & on behalf of the SIMPLIFY Study Group, Mar 2018, In: Lancet Gastroenterology and Hepatology. 3, 3, p. 153-161 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • velpatasvir
  • Sofosbuvir
  • Hepacivirus
  • Multicenter Studies
  • Virus Diseases
  104 Citations (Scopus)

  414 Downloads (Pure)